A 58-year-old man with type 2 diabetes and dyslipidaemia has persistent blood pressure readings around 162/96 mm Hg despite rigorous lifestyle interventions. He has no chronic kidney disease or established cardiovascular disease. According to Hypertension Canada, which initial pharmacological strategy is most appropriate?